🇯🇵 Japan Country × Condition
solid tumors Clinical Trials in Japan
Active clinical trials for solid tumors with research sites in Japan. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 1, Phase 1, Phase 2 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇯🇵 Japan
Active Trials in Japan (2)
NCT07030959 Phase 1
Recruiting
Study of AUBE00 in Patients With Solid Tumors
Enrollment
130 pts
Country
🇯🇵 Japan
Chugai Pharmaceutical
View Trial → NCT05101070 Phase 1, Phase 2
Recruiting
S-531011 as Monotherapy and in Combination With an Immune Checkpoint Inhibitor in Advanced or Metastatic Solid Tumors
Enrollment
282 pts
Country
🇯🇵 Japan
Shionogi
View Trial → Frequently Asked Questions
How many solid tumors clinical trials are active in Japan?
There are currently 2 active clinical trials for solid tumors with sites in Japan, of which 2 are actively recruiting patients.
How can I join a solid tumors clinical trial in Japan?
To join a solid tumors clinical trial in Japan, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Japan directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are solid tumors trials in Japan?
Active solid tumors trials in Japan span Phase 1, Phase 1, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology